Sector Investors News and Insights

EW

ROSEN, a highly rated law firm, advises investors of Edwards Lifesciences Corporation to seek legal representation before the critical deadline in the securities class action EW.

XLV Health Care / /

In New York on November 10, 2024, Rosen Law Firm, an international law firm representing investor rights, is reminding individuals who purchased securities of Edwards Lifesciences Corporation (NYSE: EW) between a certain period.

ROSEN, a highly rated law firm, advises investors of Edwards Lifesciences Corporation to seek legal representation before the critical deadline in the securities class action EW. Read More »

ROSEN, a prominent law firm, advises investors of Edwards Lifesciences Corporation to seek legal representation before the upcoming deadline for the securities class action case EW.

XLV Health Care / /

The Rosen Law Firm is reminding investors who purchased securities of Edwards Lifesciences Corporation between a certain period.

ROSEN, a prominent law firm, advises investors of Edwards Lifesciences Corporation to seek legal representation before the upcoming deadline for the securities class action case EW. Read More »

Robbins LLP, a shareholder rights law firm, is reminding investors of the deadline to appoint a lead plaintiff in the class action against Edwards Lifesciences Corporation.

XLV Health Care / /

A shareholder has filed a class action lawsuit against Edwards Lifesciences Corporation, accusing them of providing misleading information to investors.

Robbins LLP, a shareholder rights law firm, is reminding investors of the deadline to appoint a lead plaintiff in the class action against Edwards Lifesciences Corporation. Read More »

The Rosen Law Firm is advising Edwards Lifesciences Corporation (NYSE: EW) shareholders who have incurred significant losses to reach out to the firm for guidance on their legal rights.

XLV Health Care / /

The Rosen Law Firm has announced that a shareholder has submitted a class action lawsuit on behalf of all individuals who bought securities of Edwards Lifesciences Corporation (NYSE: EW) during a certain period.

The Rosen Law Firm is advising Edwards Lifesciences Corporation (NYSE: EW) shareholders who have incurred significant losses to reach out to the firm for guidance on their legal rights. Read More »

© 2025 ETF Sector

Scroll to Top

Subscribe to our Newsletter

Stay updated with the latests analysis and insights fromm etfsector.com